PK and Safety of Midostaurin in Subjects With Impaired Hepatic Function and Subjects With Normal Hepatic Function
Clinical trial NCT01429337 · COMPLETED
Trial details
- NCT number
- NCT01429337
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-07
- Primary completion
- 2020-04-13
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.